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Supporting text S1 | Effect of drug therapy on CP and free hydroxyproline. The effect of 
drug therapy on CP and Hyp in patients with aRA was evaluated. Patients receiving anti-
TNFα therapy had lower plasma Hyp with respect to those not receiving anti-TNFα therapy 
(0.96 µM versus 3.37 µM, P<0.01). Patients receiving treatment with non-steroidal anti-
inflammatory drugs (NSAIDs) had lower synovial fluid CP (0.15 versus 1.02 mmol/mol arg, 
P<0.05) and plasma Hyp (0.99 µM versus 3.16 µM, P<0.01) with respect to those not 
receiving NSAIDs. However, patients receiving treatment with prednisolone had higher 
synovial fluid CP (1.72 versus 0.24 mmol/mol arg, P<0.01) and plasma Hyp (2.87 versus 
0.94 µM, P<0.05) with respect to those not receiving prednisolone. Treatment with or without 
methotrexate and opiate analgesics was not associated with differences in these variables.
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Table S1 | Analytical variables and assay characteristics for quantitation of citrulline, arginine and 4-hydroxyproline by stable isotopic dilution 
analysis tandem mass spectrometry. 
Analyte Citrulline Arginine 4-Hydroxyproline 
Retention time Rt (min) 13.5 16.5 5.6 
Molecular  ion  M+1 (Da) 176.1 175.1 132.0 
Fragment ion (Da) 70.1 70.1 86.1 
Cone voltage (V) 20 30 26 
Collision energy (eV) 21.0 24.0 12.0 
Neutral fragment losses H2CO2, NH2C(=O)NH2 H2CO2, NH2C(=NH)NH2 H2CO2 
Internal standard [5-
13
C,4,4,5,5-
2
H4]citrulline  [guanidino-
15
N2]arg 4,5-[
13
C2]Hydroxyproline 
Limit of detection (fmol) 62 520 102 
Intra- and interbatch CV (%; n = 6) 1.3 and 6.0 1.0 and 1.8 1.0 and 1.5 
Recovery (%) 88 (protein digest) 94 (protein digest) 100 (ultrafiltrate) 
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Table S2 | Cross validation of multiclass algorithm. Improved outcome with training set and 
test set cohorts combined using GLMNET algorithm and randomly assigning 67% samples to 
training set and 33% to the test set. 
A. Multi-class analysis for GLMNET algorithm  
 Control eOA eRA non-RA 
nCorrect 13/17 10/14 10/15 7/15 
Sensitivity 0.76 (0.50 – 0.93) 0.71 (0.42 – 0.92) 0.67 (0.38 – 0.88) 0.47 (0.21 – 0.72) 
Specificity 0.77 (0.62 – 0.89) 0.96 (0.85 – 0.99) 1.00 (0.92 – 1.00) 0.80 (0.66 – 0.91) 
F-Measure 0.65 0.77 0.80 0.45 
 
B.  Confusion matrix for GLMNET algorithm 
 Predicted class 
Control Early OA Early RA non-RA 
Clinical 
class 
Control 13 2 0 8 
eOA 2 10 0 0 
eRA 0 0 10 0 
non-RA 2 2 5 7 
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Figure S1 | Bland-Altman plots for (a) CP and (b) Hyp measurements.  Data from samples 
analysis of 12 subjects (7 healthy controls and 5 eOA) was evaluated. There was no 
proportional bias but one outlier was identified in the Hyp measurements. 
 
 
 
